Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleEXPERT COMMENTARY ON THE PRODUCT PROFILE OF Amivantamab-vmjw.SubjectsTHERAPEUTIC use of monoclonal antibodies; THERAPEUTIC use of antineoplastic agents; LUNG cancer; DRUG efficacy; EPIDERMAL growth factor receptors; MONOCLONAL antibodies; MEDICAL personnel; EXPERTISE; DRUG interactions; PHARMACY information services; DRUG toxicity; PATIENT safety; MEDICAL researchPublicationOncology (08909091), 2022, Vol 36, Issue 3, p186ISSN0890-9091Publication typeArticle